{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:01:25Z","timestamp":1767891685355,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.tracli.2024.11.005","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T02:33:37Z","timestamp":1732156417000},"page":"112-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potential advantage of therapeutic plasma exchange over intravenous immunoglobulin in children with axonal variant of Guillain-Barr\u00e9 syndrome: A report of six paediatric cases"],"prefix":"10.1016","volume":"32","author":[{"given":"Joyisa","family":"Deb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita","family":"Negi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswin K.","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indar Kumar","family":"Sharawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradip","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepali","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daljit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tracli.2024.11.005_b0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 syndrome and variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol Clin"},{"issue":"7","key":"10.1016\/j.tracli.2024.11.005_b0010","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1007\/s00415-020-09742-2","article-title":"Axonal variants of Guillain-Barr\u00e9 syndrome: an update","volume":"268","author":"Shang","year":"2021","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.tracli.2024.11.005_b0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2013evidence\u2010based approach from the writing committee of the American Society for Apheresis: The Ninth Special Issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apheresis"},{"issue":"5","key":"10.1016\/j.tracli.2024.11.005_b0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-0404.2001.103005267.x","article-title":"Axonal Guillain-Barr\u00e9 syndrome: a critical review","volume":"103","author":"Chowdhury","year":"2001","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"10.1016\/j.tracli.2024.11.005_b0025","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","article-title":"Outcome and its predictors in Guillain-Barr\u00e9 syndrome","volume":"83","author":"Rajabally","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.tracli.2024.11.005_b0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tracli.2024.11.005_b0035","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231154306","article-title":"Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review","volume":"16","author":"Pinto","year":"2023","journal-title":"Therapeut Adv Neurol Disord"},{"issue":"6","key":"10.1016\/j.tracli.2024.11.005_b0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jca.21646","article-title":"Cost-minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulin","volume":"33","author":"Maheshwari","year":"2018","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.005_b0045","article-title":"Treatment efficacy of plasmapheresis versus intravenous immunoglobulin in Guillain-Barr\u00e9 syndrome management: a systematic review","volume":"16","author":"Nandeesha","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.005_b0050","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2013evidence-based approach from the writing committee of the American society for apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.005_b0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2013evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.tracli.2024.11.005_b0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/0973-6247.165834","article-title":"Therapeutic plasma exchange in pediatric patients of Guillain-Barre syndrome: experience from a Tertiary Care Centre","volume":"10","author":"Gajjar","year":"2016","journal-title":"Asian J Transfus Sci"},{"issue":"10280","key":"10.1016\/j.tracli.2024.11.005_b0065","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.tracli.2024.11.005_b0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/ijmr.IJMR_995_14","article-title":"Guillain-Barre syndrome: demographics, clinical profile & seasonal variation in a tertiary care centre of central India","volume":"145","author":"Shrivastava","year":"2017","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.tracli.2024.11.005_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc10305","article-title":"Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barr\u00e9 syndrome: a randomized study","volume":"15","author":"El-Bayoumi","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.tracli.2024.11.005_b0080","series-title":"Apheresis: principles and practice","year":"2020"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.005_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.9696","article-title":"Therapeutic plasma exchange as a first\u2013choice therapy for axonal Guillain-Barr\u00e9 syndrome: a case\u2013based review of the literature","volume":"21","author":"Stoian","year":"2021","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.tracli.2024.11.005_b0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0310057X1003800225","article-title":"Plasmapheresis treatment in Guillain-Barr\u00e9 syndrome: potential benefit over intravenous immunoglobulin","volume":"38","author":"Buzzigoli","year":"2010","journal-title":"Anaesth Intensive Care"},{"issue":"4","key":"10.1016\/j.tracli.2024.11.005_b0095","article-title":"Acute respiratory failure in patients with Guillain-Barr\u00e9 syndrome and myasthenic crisis treated with plasmapheresis in the intensive care unit","volume":"118","author":"Szczeklik","year":"2008","journal-title":"Polskie Archiwum Medycyny Wewn\u0119trznej\u00a0=\u00a0Polish Arch Intern Med"},{"issue":"5","key":"10.1016\/j.tracli.2024.11.005_b0100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jca.22020","article-title":"Successful treatment with therapeutic plasmapheresis of a pediatric patient with Guillain-Barr\u00e9 syndrome associated with neurobrucellosis","volume":"37","author":"Varol","year":"2022","journal-title":"J Clin Apher"},{"issue":"4","key":"10.1016\/j.tracli.2024.11.005_b0105","doi-asserted-by":"crossref","first-page":"A703","DOI":"10.1016\/j.chest.2021.07.667","article-title":"A case of IVIG refractory Guillain-Barr\u00e9 syndrome in the setting of subclinical COVID-19 infection","volume":"160","author":"Deleveaux","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.tracli.2024.11.005_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000505964","article-title":"Child with Guillain-Barr\u00e9 syndrome responding to plasmapheresis: a case report","volume":"3","author":"Al Hamdani","year":"2020","journal-title":"Case Rep Acute Med"},{"issue":"5","key":"10.1016\/j.tracli.2024.11.005_b0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1526-0968.2004.00183.x","article-title":"Plasmapheresis treatment in Guillain-Barr\u00e9 syndrome: potential benefit over IVIg in patients with axonal involvement","volume":"8","author":"Dada","year":"2004","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.005_b0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.pepo.2013.02.006","article-title":"Antiganglioside antibodies determine the clinical severity and predict response to therapy in Egyptian children with Guillain-Barr\u00e9 syndrome","volume":"88","author":"El-Beleidy","year":"2013","journal-title":"Pediatr Pol"},{"key":"10.1016\/j.tracli.2024.11.005_b0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/1097-4598(200101)24:1<54::AID-MUS6>3.0.CO;2-9","article-title":"Intravenous immunoglobulin therapy for Guillain-Barr\u00e9 syndrome with IgG anti-GM1 antibody","volume":"24","author":"Kuwabara","year":"2001","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.tracli.2024.11.005_b0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5535\/arm.2016.40.3.481","article-title":"Prediction of functional outcome in axonal Guillain-Barre syndrome","volume":"40","author":"Sung","year":"2016","journal-title":"Ann Rehabil Med"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782024001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782024001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:51:20Z","timestamp":1740549080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782024001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1246782024001290"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2024.11.005","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential advantage of therapeutic plasma exchange over intravenous immunoglobulin in children with axonal variant of Guillain-Barr\u00e9 syndrome: A report of six paediatric cases","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2024.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\ufffdt\ufffd francophone de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}